Rapid reduction in the incidence of cancer of unknown primary. A population-based study.
Cancer of unknown primary (CUP) carries a dismal prognosis due to the two hallmarks of 1) being metastatic with 2) no known specific treatment. An organ-labeled diagnosis of cancer should therefore be sought. In this study, we have analyzed population-based incidence and survival data of CUP over the latest 40 years. Complete national data on 23 004 CUP-patients from the Cancer Registry of Norway sampled from 1971 to 2010 are presented, with absolute and age-adjusted incidence rates correlated to the total cancer incidence. One-year relative survival rates were calculated. The incidence of CUP increased both in absolute numbers and as a fraction of total cancer incidence during the first half of the period. There has been a substantial decrease in incidence over the latest 20 years, now being responsible of only 1.7% and 1.2% of the total cancer incidence in females and males, respectively, with an age-adjusted incidence rate of 3.5 and 3.8, respectively. The one-year relative survival rate has increased and was slightly below 20% for both sexes in 2010. Better diagnostics, both radiological and pathological, is probably responsible for a substantially lower incidence. Improved treatment for cancers in general also benefits the CUP-group.